EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62021TN0477
Case T-477/21: Action brought on 9 August 2021 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler)
Case T-477/21: Action brought on 9 August 2021 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler)
Case T-477/21: Action brought on 9 August 2021 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler)
OJ C 382, 20.9.2021, p. 34–35
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
20.9.2021 |
EN |
Official Journal of the European Union |
C 382/34 |
Action brought on 9 August 2021 — Glaxo Group v EUIPO — Cipla Europe (Shape of an inhaler)
(Case T-477/21)
(2021/C 382/47)
Language of the case: English
Parties
Applicant: Glaxo Group Ltd (Brentford, United Kingdom) (represented by: T. de Haan and F. Verhoestraete, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Cipla Europe NV (Antwerp, Belgium)
Details of the proceedings before EUIPO
Proprietor of the trademark at issue: Applicant before the General Court
Trade mark at issue: European Union tridimensional mark (Shape of an inhaler) — European Union trade mark No 2 179 562
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the First Board of Appeal of EUIPO of 19 May 2021 in Case R 1835/2016-1
Form of order sought
The applicant claims that the Court should:
|
— |
set aside the contested decision; |
|
— |
order EUIPO and the intervener to bear the costs, including those incurred by the applicant before the Office’s First Board of Appeal. |
Pleas in law
|
— |
Infringement of Articles 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council and 41(2) of the Charter of Fundamental Rights of the EU; |
|
— |
Infringement of Article 7(1)(b) of Council Regulation (EC) 40/94; |
|
— |
Infringement of Article 52(2) of Council Regulation (EC) 207/2009. |